The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term safety and efficacy of lanreotide treatment in Japanese patients with neuroendocrine tumors: Final analysis of a phase II open-label extension study.
 
Tetsuhide Ito
Consulting or Advisory Role - Teijin Pharma; Teijin Pharma; Teijin Pharma; Teijin Pharma
Speakers' Bureau - Teijin Pharma; Teijin Pharma; Teijin Pharma; Teijin Pharma
 
Seiichi Hisamatsu
Employment - Teijin Pharma; Teijin Pharma; Teijin Pharma; Teijin Pharma
Stock and Other Ownership Interests - Teijin Pharma; Teijin Pharma; Teijin Pharma; Teijin Pharma
 
Akihiro Nakajima
Employment - Teijin Pharma; Teijin Pharma; Teijin Pharma; Teijin Pharma
Stock and Other Ownership Interests - Teijin Pharma; Teijin Pharma; Teijin Pharma; Teijin Pharma
 
Akira Shimatsu
Consulting or Advisory Role - Teijin Pharma; Teijin Pharma; Teijin Pharma; Teijin Pharma
Speakers' Bureau - Teijin Pharma; Teijin Pharma; Teijin Pharma; Teijin Pharma